Abstract
Atopic dermatitis (AD) is the most common chronic inflammatory skin condition. This review highlights most recent advances in understanding and treating this debilitating disease. We are summarizing new insights regarding molecular endotypes and clinical phenotypes that characterize AD, the role of the skin microbiome, and improvements in diagnostic tools. We also emphasize recent scientific advancements in understanding the mechanisms driving AD pathogenesis and discuss the identification and implementation of new targeted treatment approaches that have revolutionized therapeutic options for affected patients.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call